Loss of MMP12 in LAL-D and cardiometabolic disease
Description: Immunotherapeutic Approach; Matrix Metalloproteinase-12; Lysosomal Acid Lipase Deficiency; Mutant Mouse Models; Cardiometabolic Disease; Humans
Funder: Austrian Science Fund
Amount: €407,800
Funding type: grant
Funder scheme: Einzelprojekte
Start date: 2019-09-01
End date: 2024-02-29
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Funded outputs count: 29
Funder award ID: P 32400
OpenAlex ID: G7645568245
